Suppr超能文献

血管加压素拮抗剂的研发。

The development of vasopressin antagonists.

作者信息

Sawyer W H, Manning M

出版信息

Fed Proc. 1984 Jan;43(1):87-90.

PMID:6317468
Abstract

Antagonists of the physiological actions of vasopressin can be useful probes for detecting the influences of endogenous vasopressin on cardiovascular regulation. Antagonists that block vascular receptors of the V1 type have been widely used for this purpose. Recently effective antagonists of renal antidiuretic receptors of the V2 type have become available, and we have made progress toward improving their specificity for V2 receptors. Vasopressin antagonists of both types of responses could become useful in the diagnosis and treatment of pathophysiological states in which elevated levels of circulating vasopressin may disturb cardiovascular and renal functions.

摘要

血管加压素生理作用的拮抗剂可作为有用的探针,用于检测内源性血管加压素对心血管调节的影响。阻断V1型血管受体的拮抗剂已广泛用于此目的。最近,V2型肾抗利尿受体的有效拮抗剂已问世,我们在提高其对V2受体的特异性方面取得了进展。这两种反应的血管加压素拮抗剂可能在诊断和治疗病理生理状态中发挥作用,在这些状态下,循环血管加压素水平升高可能会干扰心血管和肾功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验